Physician

Nicholas C Mexas, D.O.

According to 2025 Medicare claims, Nicholas Mexas, D.O. (NPI: 1396743100) practices internal medicine in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is DERMAHEAL, LLC (NPI: 1427598580; TIN: 815389520) and primary practice location at 29527-6002.

Mexas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 342 traditional Medicare patients, billed 6,656 HCPCS/CPT codes, and received $3,128,863 in Medicare payments. The top billing code was 99305 (Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes). Part D data shows 565 prescription claims across 105 beneficiaries totaling $10,965 in drug costs, led by Losartan Potassium (Losartan Potassium). 2023 DME data shows 488 claims. Open Payments data shows 4 records totaling $89. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $92,622 to $3,128,863. In contrast, Part D prescription costs have fallen sharply in recent years, from $19,269 to $10,965. For DME billing, reported payments moved sharply higher in recent years, from $5,742 to $93,622.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	535	1,343	$92,622
2016	563	1,208	$86,706
2017	597	1,151	$85,758
2018	551	1,344	$90,380
2019	460	1,101	$74,407
2020	395	1,045	$72,632
2021	271	1,728	$93,033
2022	283	2,916	$225,560
2023	376	2,910	$344,289
2024	342	6,656	$3,128,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	136	344	$19,269
2016	131	390	$24,162
2017	109	396	$47,705
2018	95	250	$29,828
2019	121	410	$32,088
2020	120	430	$31,080
2021	129	317	$16,619
2022	91	207	$19,847
2023	96	230	$5,749
2024	105	565	$10,965

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	59	$2,312
2017	N/R	47	$8,861
2018	N/R	30	$8,498
2019	N/R	12	$8,789
2020	N/R	22	$1,209
2021	208	432	$34,980
2022	230	496	$42,636
2023	322	488	$57,322
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99305	Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes	172	179	$99
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	82	156	$80
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	149	432	$55
11042	Removal of skin and tissue, 20.0 sq cm or less	73	173	$45
99307	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes	169	353	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Losartan Potassium	Losartan Potassium	18	448	$247
Levothyroxine Sodium	Levothyroxine Sodium	50	802	$183
Morphine Sulfate	Morphine Sulfate	13	93	$175
Carbidopa-Levodopa	Carbidopa/Levodopa	13	190	$143
Quetiapine Fumarate	Quetiapine Fumarate	22	328	$121

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$89	Organogenesis Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicholas C. Mexas, D.O.?

Tedicare shows public-source Medicare data for Nicholas C. Mexas, D.O. (NPI 1396743100), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas C. Mexas, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nicholas C. Mexas, D.O.?

Nicholas C. Mexas, D.O. is linked to DERMAHEAL, LLC (billing NPI 1427598580) in the available physician profile data.

Does Nicholas C. Mexas, D.O. have Open Payments data?

Nicholas C. Mexas, D.O. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.